Bond Bull Market Shows Signs of Pause but Remains Resilient Expert Suggests Grab Group CEO Anthony Tan Wins Top Honor at 41st Singapore Business Awards Qualcomm Stock Surges as Investors Eye AI Device Boom Samsung Chip Workers Potential Bonus Reaches 432000 Average Under Tentative Strike Agreement Goldman Sachs CD Offering at 4 Outpaces Average Bank Rates National Music Centre Appoints Steve Kane as Board Chair Announces Governance Updates BSBK Q1 2025 Earnings Modest Profitability Maintained as Bank Navigates Stable Operating Environment VLRS Q1 2026 Earnings EPS Beats Expectations but Stock Slips on Revenue Uncertainty MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Airship AI Holdings Inc AISP Q3 2025 Earnings Significant EPS Miss Amidst Lack of Revenue Disclosure Argan Inc AGX Q1 2026 Earnings EPS Surges 737 Above Estimates Shares Climb Nearly 2 SOBO Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ITHAX Acquisition Corp III Warrants ITHAW Holds Steady at 024 as Support and Resistance Levels Tighten Core Scientific CORZ Regains Ground as Bitcoin Miners Eye Key Resistance ADAMI Senior Notes Slip Slightly as FixedIncome Market Faces Mixed Signals ZK International Group ZKIN Shares Slide 7 as Resistance Holds Firm Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives FMBH Q1 2026 Earnings EPS Surpasses Expectations Stock Moves Lower Youxin Technology YAAS Slides 220 Tests Key Support at 076 Amid Light Selling Pressure Andy Burnhams Manchester Model A Regional Economic Philosophy That Could Shape UK Policy White House Touts Soybean and Rare Earths Deals Following TrumpXi Summit as China Signals Tariff Reductions EU Green Economy Output Doubles in Decade as Solar Energy Surges at Record Pace Japanese Snack Maker Behind Shiruko Sand Targets Singapore and Southeast Asia for Expansion Surge in LongDated Treasury Yields Prompts Bond Investors to Reassess RiskFree Assumptions Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse Prediction Market Investments Continue Despite Regulatory Uncertainty Companies Reaffirm Growth Plans in Earnings Calls